World’s First MAGE-A4-Targeting TCR-NK Therapy Zelluna Doses First Patient in Clinical Trial
Zelluna ASA, a Norwegian biotech company pioneering allogeneic cell therapies for solid cancers, recently announced that the first patient has received the first dose of ZI-MA4-1 in the ZIMA-101 Phase 1 clinical trial. The treatment was administered at The Christie NHS Foundation Trust in Manchester,…
When Synovial Sarcoma Mimics the Heart’s Most Common Tumor
A case report in AME Case Reports by Yun Xiao, Zhourui Liu, and Sha Li of the Department of Ultrasound at Guizhou Medical University, China, documents a rare case of synovial sarcoma arising directly in the pulmonary artery, a location so uncommon that it was…
Closing the AYA Gap: Clinical Trials, Genetic Testing, and Palliative Care for Young Sarcoma Patients
A new educational review in the American Society of Clinical Oncology Educational Book, authored by Sophie Jessop, MBBS, and colleagues, examines three persistent gaps in care for adolescents and young adults (AYAs) with sarcoma: clinical trial access, genetic testing for inherited cancer risk, and timely…
Rare Synovial Sarcoma Cases Highlight New Limb-Sparing Reconstruction Approach
A new case report published in the World Journal of Surgical Oncology explored an innovative reconstruction technique for rare soft…
Research Highlights Importance of Patient-Centered Sarcoma Surveillance
A 2022 study explored how sarcoma patients feel about long-term surveillance imaging after treatment, highlighting the emotional, financial, and practical…
Study Finds Tumor Size and Surgical Margins are Key Drivers of Synovial Sarcoma Outcomes
A new multi-center retrospective study from three major U.S. sarcoma centers has analyzed outcomes in patients with localized synovial sarcoma,…
North America Synovial Sarcoma Treatment Market Expected to Grow Through 2033
New industry analyses project continued growth in the North America synovial sarcoma treatment market, with a predicted compound annual growth…
Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis
Synovial sarcoma is a rare and aggressive soft tissue cancer that most often develops near the joints of the arms…
Synovial Sarcoma Foundation Wins First Place at the 16th Annual SPAGN Conference
We are incredibly honored to share that the Synovial Sarcoma Foundation received First Place in the Advocacy in Action Award…
Synovial Sarcoma Foundation Welcomes Lucia and Roberto Belluco to the Board of Directors
[Philadelphia, PA] The Synovial Sarcoma Foundation (SSF) is honored to welcome Lucia Manzinello Belluco and Roberto Belluco to its Board…
Synovial Sarcoma Research and Rare Cancer Drug Development: Challenges and Progress
Developing treatments for rare cancers like synovial sarcoma remains one of the biggest challenges in modern medicine—but recent progress shows…
New Research Identifies 4 Subtypes of Synovial Sarcoma, Opening Doors for Personalized Treatment
Synovial sarcoma is a rare and aggressive soft tissue cancer, but new research is helping us better understand how it…
